A Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet Donations
Not Applicable
Completed
- Conditions
- eukaemia (acute), Leukaemia (chronic)CancerLeukaemia (acute), Leukaemia (chronic)
- Registration Number
- ISRCTN43344383
- Lead Sponsor
- Pall Biomedical Ltd (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with acute leukaemia, chronic myeloid leukaemia, severe aplastic anaemia or high grade lymphoma
2. Patients already known to have Human Leukocyte Antigens (HLA) antibodies or recurrent febrile transfusion reactions are ineligible
3. Any age
4. Fit to undergo the treatments as defined in protocol
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method